⑴ Official in charge of disbursement of the procuring entity : Tetsuro Odaira, Director, National Hospital Organization Nishiniigata Chuo Hospital

⑵ Classification of the products to be procured : 7

⑶ Nature and quantity of the products to be purchased :

MYOZYME 50mg 848vials

SPINRAZA Intrathecal injection 12mg 8vials

Brineura Intracerebroventricular Injectable Solution 150mg 54vials

Viltepso Injection 368vials

Zolgensma Infusion

NEXVIAZYME for I.V. Infusion 114vials

EVRYSDI Dry Syrup 60mg 26vials

⑷ Delivery period : From the day of concluding a contract to September 30, 2023

⑸ Delivery place : The medicine part

⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;

② not come under Article 6 of the Regulation concerning Contract for NHO ;

③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and ageny) in Kanto-Koshinetsu Region ;

④ prove to have obtained the firstclasslicense for selling drugs in accordance with the Pharmaceutical Affairs Law ;

⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;

⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;

⑺ Time-limit for tender : 10 : 00 A.M. September 26, 2022

⑻ Contact point for the notice : Shinichi Hattori, Director, National Hospital Organization Nishiniigata Chuo Hospital 1-14-1 Masago, Nishi-ku, Niigata-shi, Niigata-ken 950-2085, Japan, TEL 025-265-3171 ext. 1020